Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
62 hedge funds and large institutions have $30M invested in Applied Genetic Technologies Corporation in 2017 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 10 increasing their positions, 24 reducing their positions, and 14 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
7% less funds holding
Funds holding: 67 → 62 (-5)
11% less capital invested
Capital invested by funds: $33.6M → $30M (-$3.56M)
29% less first-time investments, than exits
New positions opened: 10 | Existing positions closed: 14
58% less repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 24
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
6CM
683 Capital Management
New York
|
+$816K |
| 2 |
MERSOM
Municipal Employees' Retirement System of Michigan
Lansing,
Michigan
|
+$471K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$429K |
| 4 |
Renaissance Technologies
New York
|
+$412K |
| 5 |
SIM
Spark Investment Management
New York
|
+$224K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$724K |
| 2 |
Millennium Management
New York
|
-$394K |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$332K |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$241K |
| 5 |
American Century Companies
Kansas City,
Missouri
|
-$222K |
AGTC Hedge Fund Activity: Q4 2017 in Review
62 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2017, worth a combined $30M — down 11% from $33.6M a quarter earlier.
Sellers outnumbered buyers: 14 funds closed out of AGTC and 10 opened new positions — a net loss of 4 holders — while 24 trimmed existing stakes and 10 added.
The largest buyer was 683 Capital Management, opening a new position worth an estimated $816K. The largest seller was Fidelity Investments, cutting an estimated $724K.
- 62 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2017, down from 67 in Q3 2017.
- Funds reported $30M of Applied Genetic Technologies Corporation stock for Q4 2017, down 11% quarter-over-quarter.
- 10 funds opened new Applied Genetic Technologies Corporation positions in Q4 2017 and 14 closed out, a net change of -4 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q4 2017 was 683 Capital Management, an estimated $816K added.
- The largest Applied Genetic Technologies Corporation seller in Q4 2017 was Fidelity Investments, an estimated $724K sold.
Based on aggregated 13F filings for Q4 2017.